Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Positive phase IIa results for therapeutic vaccine for genital warts

Dec. 13, 1996

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Dec. 13, 1996

New immunostimulant from Snow Brand

Dec. 13, 1996

NAVA-Chiron Behring vaccine distribution agreement signed

Dec. 12, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Oral influenza vaccine from Cortecs enters clinic

Dec. 4, 1996

AADA filed for generic ciclosporin

Dec. 3, 1996

Vasogen autocellular response therapy appears effective in RA

Nov. 29, 1996

Partners sought for 3DP MHC blockers

Nov. 29, 1996

Disappointing results reported for genital herpes vaccine

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...